Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v2.4.0.6
Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Operating activities:    
Net income $ 42,395 $ 22,075
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 14,092 16,120
Compensation expense related to share-based awards 1,218 669
Provision (benefit) for deferred income taxes (20,501) 15
Loss on disposal of property, plant and equipment 1,645 310
Other 193 (268)
Change in assets and liabilities, net of the effects from acquired and divested businesses:    
Accounts receivable (3,108) (3,875)
Inventories 946 3,462
Prepaid and other current assets (2,497) 4,854
Other assets 150 473
Customer deposits (1,622) (90)
Accounts payable (303) 1,418
Accrued expenses (3,519) (5,288)
Other liabilities (1,256) 711
Net cash provided by operating activities 27,833 40,586
Investing activities:    
Proceeds from the disposal of property, plant & equipment 1,792 145
Change in restricted cash and investments 981 953
Capital expenditures (19,836) (5,731)
Acquistions (520) (611)
Purchases of marketable securities (3,290) (8,214)
Sales of marketable securities 4,675 6,069
Other 773 (456)
Net cash used in investing activities (15,425) (7,845)
Financing activities:    
Payments on long-term debt and capital lease obligations (12,145) (26,070)
Proceeds from issuance of common stock 225 29
Proceeds from non controlling interest 275  
Payments of deferred financing costs   (125)
Payment of cash dividends (6,046) (4,313)
Purchases and other retirements of company stock (847) (5,377)
Net cash used in financing activities (18,538) (35,856)
Effect of exchange rate changes on cash 741 75
Net decrease in cash & cash equivalents (5,389) (3,040)
Cash & cash equivalents at beginning of period 78,519 73,852
Cash & cash equivalents at end of period $ 73,130 $ 70,812